Development and evaluation of a self-report tool to predict low pharmacy refill adherence in elderly patients with uncontrolled hypertension

Pharmacotherapy

Volumn 33, Issue 8, 2013, Pages 798-811

  Krousel Wood, Marie ^a,b,c   Joyce, Cara ^c   Holt, Elizabeth W ^a,c   Levitan, Emily B ^d   Dornelles, Adriana ^a   Webber, Larry S ^c   Muntner, Paul ^d  

^a OCHSNER CLINIC FOUNDATION   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TULANE UNIVERSITY   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Hypertension; Medication adherence; Pharmacy refill; Risk prediction; Uncontrolled blood pressure

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; CLINICAL ASSESSMENT TOOL; CROSS-SECTIONAL STUDY; DEPRESSION; DIAGNOSTIC TEST ACCURACY STUDY; ELDERLY CARE; FEMALE; FUNCTIONAL STATUS; HEALTH SURVEY; HILL BONE COMPLIANCE SCALE; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MORISKY MEDICATION ADHERENCE SCALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PREDICTION; QUALITY OF LIFE; RATING SCALE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; SENSITIVITY AND SPECIFICITY; SOCIAL SUPPORT; STRESS; SYSTOLIC BLOOD PRESSURE;

EID: 84885209940     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1002/phar.1275     Document Type: Review

References (48)

1. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72.
2. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010;303:2043-50.
3. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012;125:e2-220.
4. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217-23.
5. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA 2002;288:2880-3.
6. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 2002;40:794-811.
7. Kravitz RL, Melnikow J. Medical adherence research: time for a change in direction? Med Care 2004;42:197-9.
8. Krousel-Wood MA, Muntner P, Islam T, Morisky DE, Webber LS. Barriers to and determinants of medication adherence in hypertension management: perspective of the cohort study of medication adherence among older adults. Med Clin North Am 2009;93:753-69.
9. Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Prog Cardiovasc Nurs 2000;15:90-6.
10. Morisky DE, Ang A, Krousel-Wood MA, Ward H. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens 2008;10:348-54.
11. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74.
12. Koschack J, Marx G, Schnakenberg J, Kochen MM, Himmel W. Comparison of two self-rating instruments for medication adherence assessment in hypertension revealed insufficient psychometric properties. J Clin Epidemiol 2010;63:299-306.
13. Bailey JE, Wan JY, Tang J, Ghani MA, Cushman WC. Antihypertensive medication adherence, ambulatory visits, and risk of stroke and death. J Gen Intern Med 2010;25:495-503.
14. Ho PM, Magid DJ, Shetterly SM, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J 2008;155:772-9.
15. Kettani FZ, Dragomir A, Cote R, et al. Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention. Stroke 2009;40:213-20.
16. Steiner JF, Ho PM, Beaty BL, et al. Sociodemographic and clinical characteristics are not clinically useful predictors of refill adherence in patients with hypertension. Circ Cardiovasc Qual Outcomes 2009;2:451-7.
17. Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol 2004;19:357-62.
18. Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care 2009;15:59-66.
19. Rizzo JA, Simons WR. Variations in compliance among hypertensive patients by drug class: implications for health care costs. Clin Ther 1997;19:1446-57.
20. Sikka R, Xia F, Aubert RE. Estimating medication persistency using administrative claims data. Am J Manag Care 2005;11:449-57.
21. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
22. Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med 1991;32:705-14.
23. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-item health survey 1.0. Health Econ 1993;2:217-27.
24. Holt EW, Muntner P, Joyce CJ, Webber L, Krousel-Wood MA. Health-related quality of life and antihypertensive medication adherence among older adults. Age Ageing 2010;39:481-7.
25. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983;24:385-96.
26. Ogedegbe G, Mancuso CA, Allegrante JP, Charlson ME. Development and evaluation of a medication adherence selfefficacy scale in hypertensive African-American patients. J Clin Epidemiol 2003;56:520-9.
27. National Center for Health Statistics. National Health and Nutrition Examination Study. Atlanta, GA: NCHS, Centers for Disease Control and Prevention. Available from http://www. cdc.gov/nchs/data/nhanes/nhanes2003-2004/ BPQ-C.htm. Accessed February 1, 2011.
28. Krousel-Wood MA, Muntner P, Joyce CJ, et al. Adverse effects of complementary and alternative medicine on antihypertensive medication adherence: findings from the cohort study of medication adherence among older adults. J Am Geriatr Soc 2010;58:54-61.
29. Lengacher CA, Bennett MP, Kipp KE, Berarducci A, Cox CE. Design and testing of the use of a complementary and alternative therapies survey in women with breast cancer. Oncol Nurs Forum 2003;30:811-21.
30. Krousel-Wood M, Muntner P, Jannu A, Desalvo K, Re RN. Reliability of a medication adherence measure in an outpatient setting. Am J Med Sci 2005;330:128-33.
31. Akaike H. (1973). Information theory and an extension of the maximum likelihood principle. In B.N. Petrov & F. Csaki (Eds.), Second international symposium on information theory (pp 267-281.) Budapest: Akademiai Kiado.
32. Hosmer DW, Jovanovic B, Lemeshow S. Best subsets logistic regression. Biometrics 1989;45:1265-70.
33. Schwarz G. Estimating the dimension of a model. Ann Stat 1978;6:461-4.
34. Sullivan LM, Massaro JM, D'Agostino RB Sr. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med 2004;23:1631-60.
35. Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 2001;54:774-81.
36. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-45.
37. Krousel-Wood MA, Islam T, Muntner P, et al. Medication adherence in older clinic patients with hypertension after Hurricane Katrina: implications for clinical practice and disaster management. Am J Med Sci 2008;336:99-104.
38. Kressin NR, Wang F, Long J, et al. Hypertensive patients' race, health beliefs, process of care, and medication adherence. J Gen Intern Med 2007;22:768-74.
39. Burnier M, Santschi V, Favrat B, Brunner HR. Monitoring compliance in resistant hypertension: an important step in patient management. J Hypertens Suppl 2003;21:S37-42.
40. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004;42:200-9.
41. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005;43:521-30.
42. Hawkshead J, Krousel-Wood, M. Techniques of measuring medication adherence in hypertensive patients in outpatient settings: advantages and limitations. Dis Manag Health Outcomes 2007;15:109-18.
43. Morris AB, Li J, Kroenke K, Bruner-England TE, Young JM, Murray MD. Factors associated with drug adherence and blood pressure control in patients with hypertension. Pharmacotherapy 2006;26:483-92.
44. National Center for Health Statistics. Health, United States, 2007 Chartbook on trends in the health of Americans. Hyattsville, MD: National Center for Health Statistics, 2007.
45. Cohen RA, Martinez ME. Health Insurance Coverage: early release of estimates from the National Health Interview Survey, January-March 2012. Available from http://198.246.124.22/nchs/data/nhis/earlyrelease/insur201209. pdf. Accessed September 23, 2012.
46. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-97.
47. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation 2009;119:3028-35.
48. Bokhour BG, Berlowitz DR, Long JA, Kressin NR. How do providers assess antihypertensive medication adherence in medical encounters? J Gen Intern Med 2006;21:577-83.